Pharmaceutical

The following technologies are available for licensing in this group:

Technology Updates

In order to keep in touch with people and organisations interested in Isis' technologies, we provide regular email updates on new technologies. Request Technology Updates.

Therapeutic Tolerogenic Antibodies (Isis-9)

Chiral Peptide Nucleic Acids (Isis-66)

Stealth Antibody Technology (Isis-689)

Controlled Drug Release (Isis-957)

Improved Vaccination Using Lentivirus in Prime/Boost Protocols (Isis-1428)

Comprehensive Meningococcal Vaccine (Isis-1538)

Recombinant Overlapping Peptide Vaccines for Infectious Disease and Cancer (Isis-2452)

Allergen Specific T-cell Clones for Antibody testing (Isis-2816)

Molecular Shape Recognition (Isis-2932)

A Novel Cancer Biomarker and Drug Target (Isis-3101)

Adenovirus: Vector Improvements (Isis-3266)

High Density Protein Nanoarray (Isis-3310)

High-Throughput Screening Of Membrane Proteins (Isis-3329)

HLA Typing (Isis-3337)

MVA NP + M1 Influenza Vaccine (Isis-3360)

AdCh63 ME.TRAP Malaria Vaccine (Isis-3479)

Oxford Genome-wide Association Software Suite (Isis-3507)

Improved Drug Target Characterisation and Screening (Isis-3579)

RNA interference (RNAi) Technology (Isis-3581)

A Novel Method For The Treatment Of Obesity (Isis-3593)

Novel Method for Enhancing Protein Yields in the Lab and in Large Scale Manufacture (Isis-3776)

Prime/Boost Vaccination using a Mixed Vector Approach (Isis-3991)

Novel RNAi Delivery Technology (Isis-4096)

Software for Cancer Prognosis (Isis-4142)

Cardiology Target (Isis-4222)

Ultra-Stable Streptavidin (Isis-4258)

Antigen Identification (Isis-4377)

Tailored Inorganic Adjuvants (Isis-4384)

Bipolar Disorder Drug Candidate (Isis-6897)

Efficient Cofactor Regeneration (Isis-6899)

Neurological Phase II Opportunity (Isis-7163)

Epitope Identification (Isis-7260)

Dengue Diagnostic/Vaccine Development (Isis-7262)

Fighting Cancer with Stem Cells (Isis-7381)

Novel Antibacterial Target (Isis-7401)

Anti-cancer Drug Discovery (Isis-7415)

Gene Silencing (Isis-7445)

Analysing the Neurobiology of Learning and Memory (Isis-7851)

Parkinson\'s Disease Therapeutic (Isis-7925)

Malaria Vaccine (Isis-7976)

Drug Candidate Identification (Isis-8097)

Novel Small Cannabinoid Agonists (Isis-8125)

Targeted Drug Delivery (Isis-8173)

Allergy Treatment (Isis-8248)

Prognostic Cancer Biomarker (Isis-8488)

Antiplatelet Drugs (Isis-8602)

Dupuytren’s Disease, Early Treatment (Isis-8638)

TLR Agonist for Atherosclerosis (Isis-8780)

Auto-immune/Inflammatory Treatment (Isis-8781)

Ubiquitin Research/Drug Discovery (Isis-8918)

Point of Care Insulin Blood Test (Isis-9023)

HIV Vaccine Strategy (Isis-9039)

Soluble Themis Protein (Isis-9133)

Novel Herbal Based Throat Pastilles with Antibacterial Effects (Isis-78014)

Reversible Proton-pump Inhibitor (Isis-79115)

Indication Expansion of TNF Inhibitors for Cardiovascular, Cerebrovascular and Thrombotic Conditions (Isis-788411)

Identifying Efficacious Compounds for Treating chronic Inflammatory Diseases (Isis-788416)

Platform For Vaccine Adjuvants (Isis-788417)

Endogenous Vaccine Adjuvant (Isis-788418)

Suppression of TNF- α and IL-12 in Therapy (Isis-788419)